本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

MBX Biosciences

6.37
-0.6000-8.61%
盘后6.720.3500+5.49%17:16 EDT
成交量:23.23万
成交额:151.37万
市值:2.13亿
市盈率:-1.09
高:7.15
开:6.84
低:6.33
收:6.97
数据加载中...
2025/03/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/17

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/17

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/01

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/09/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/31

SEC问询函

Form CORRESP - Correspondence